Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the health-check domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/wp-includes/functions.php on line 6121
New medicine against advanced kidney cancer – The Robotic Surgeon – Domenico Savatta, M.D.

New medicine against advanced kidney cancer

FDA approves third new targeted therapy for advanced RCC – UrologyTimes

The FDA has approved the enzyme inhibitor temsirolimus (Torisel) for the treatment of advanced renal cell carcinoma.
The approval of temsirolimus follows the December 2005 approval of sorafenib (Nexavar) and the January 2006 approval of sunitinib (Sutent), which represent a new class of targeted therapies for advanced RCC.


The article in the New England Journal of Medicine showed an improvement in survival of 3 months with temsirolimus. This will be an important addition in helping patients with advanced kidney cancer.